Author

Yan-Li Yang

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jul 2026

Relationship between endothelial activation and stress index in delirium patients and seven-day mortality: A retrospective study using inverse probability of treatment weighting

Objective In intensive care units (ICUs), delirium frequently occurs as an acute brain dysfunction and is linked to a higher risk of death. The Endothelial Activation and Stress Index (EASIX)—derived from three routine lab tests: lactate dehydrogenase, serum creatinine, and platelet count—has been proposed as a marker...

Han Shi, Yan-Li Yang, Huai Xi et al. · Science in progress · 0 citations

Clinical trial Oct 2026

Felzartamab plus lenalidomide-dexamethasone versus lenalidomide-dexamethasone for relapsed or refractory multiple myeloma: an open-label, parallel-controlled, randomised, phase 3 trial.

BACKGROUND Complement-dependent cytotoxicity (CDC) of CD38 monoclonal antibodies has been associated with infusion-related reactions and might contribute to reduced clinical efficacy of CDC-reliant CD38 antibodies, particularly in patients with relapsed or refractory multiple myeloma with 1q21+. We aimed to evaluate fe...

Hai-Yan He, J. Shang, Ya-Fei Wang et al. · The Lancet Haematology · 0 citations